Canada’s regulatory cooperation activities
On this page
Canadian Free Trade Agreement: Regulatory Reconciliation and Cooperation Table
The Canadian Free Trade Agreement (CFTA) entered into force on , replacing the Agreement on Internal Trade. The CFTA establishes the Regulatory Reconciliation and Cooperation Table (RCT) which is a federal-provincial-territorial body that oversees the regulatory reconciliation process to align regulatory frameworks between all provinces/territories, and the federal government in order to reduce barriers to trade, investment, and labour mobility within Canada. It also promotes cooperation in the development of future regulations to avoid regulatory divergences, facilitate innovation and growth in emerging industries, and streamline approval processes to minimize the administrative burden for Canadian businesses.
In 2018, the RCT released its first work plan (PDF, 158 KB) highlighting 23 items for reconciliation. Since then, the RCT has endorsed five reconciliation agreements. The 2019-2020 RCT work plan (PDF, 336 KB) , carriers over items from the previous plan and adds two new initiatives for regulatory reconciliation and three items for regulatory cooperation.
Canada-European Union Comprehensive Economic and Trade Agreement- Regulatory Cooperation Forum
The Canada-European Union Comprehensive Economic and Trade Agreement (CETA) (PDF, 1.45 MB) entered into force provisionally on . It is the first Canadian bilateral trade agreement with a stand-alone chapter on regulatory cooperation. The chapter establishes the Regulatory Cooperation Forum (RCF) to facilitate and promote regulatory cooperation between Canada and the European Union (EU). To achieve this, the RCF will consider a broad range of regulatory measures in order to improve regulatory planning, promote transparency, and enhance the efficacy of regulations by seeking to reduce duplication and misalignment. These efforts will help lower trade barriers, make it easier for Canadians to do business in the EU, and improve choice for Canadian consumers.
The next Canada-European Union (EU) Comprehensive Economic and Trade Agreement (CETA) Regulatory Cooperation Forum (RCF) will take place on Monday February 3, 2020 in Ottawa, Canada. Following this meeting, on Tuesday, February 4, 2020 Canadian and EU co-chairs will provide a debrief to stakeholders on all active work plan items in the areas of consumer product safety, cosmetic like drug products, pharmaceutical inspections, animal welfare, cybersecurity, and other areas of consideration.
The first face-to-face meeting of the RCF took place on Friday, December 14, 2018 in Brussels, Belgium.
The RCF Work Plan outlines the ongoing activities of the RCF to address issues of regulatory misalignment and barriers to trade. The work plan is a rolling work plan in which new items can be brought forward and added at any time, with the agreement of the RCF Co-chairs. Work plan items are informed by input from Canadian and EU regulators and stakeholders.
Canada-U.S. Regulatory Cooperation Council
The Canada-United States (U.S.) Regulatory Cooperation Council (RCC) provides regulators from Canada and the U.S. the opportunity to work together to reduce unnecessary burden on stakeholders, while continuing to protect the health and safety of citizens and the environment.
The RCC provides a forum for stakeholders, including industry, consumers, and non-government organizations, to discuss regulatory barriers and identify opportunities for regulatory cooperation.
The following technical work plans are based on ongoing discussions between Canadian and U.S. regulators. The following table includes links to the 2019-20 RCC Work Plans:
|Work Plan||Canadian Department||U.S. Department||Objective|
|Globally Harmonized System for Classification and Labelling of Chemicals||Health Canada||U.S. Department of Labor||The objective of this collaboration is to ensure that the Canadian and U.S. requirements for hazard classification and communication remain aligned to the greatest extent possible with each other and with the GHS as it is updated. Where possible, the objective is to have one label and one safety data sheet (SDS) that would be acceptable in both countries, while respecting the legislative and regulatory requirements of each country and without reducing the level of safety or protection to workers.|
|Pesticides||Health Canada||U.S. Environmental Protection Agency||The US Environmental Protection Agency's (US EPA) Office of Pesticide Programs (OPP) and Health Canada's Pest Management Regulatory Agency (PMRA) are working together to foster an atmosphere of ongoing cooperation, collaboration, and regular communication to better align regulatory approaches in the following areas: Alignment of Pesticide Residue Chemistry; Joint Review (JR) Process Improvements (New Chemicals/Uses); Pesticide Re-evaluation and Post-Market Joint Reviews; Pollinator Protection and Neonicotinoid Pesticides; Pest Control Emerging Technologies; New Approach Methodologies (NAMs); and, Emerging Pesticide Issues.|
|Medical Devices||Health Canada||U.S. Food and Drug Administration||Health Canada and the U.S. Food and Drug Administration (FDA) will continue to work together on pre and post market regulatory convergence topics, including in particular, through the International Medical Devices Regulators Forum (IMDRF). The IMDRF aims to accelerate international medical device regulatory harmonization and convergence for regulators and stakeholders worldwide. Building upon existing regulatory harmonization initiatives, Health Canada and the FDA will work towards the development of the Medical Device Single Review Program (MDSRP) to improve patient access to medical devices, support innovation, and strengthen standards development. The MDSRP development process, pilot, and program launch will take place over two years from 2019 to 2021.|
|Veterinary Drugs||Health Canada||U.S. Food and Drug Administration||The FDA and Health Canada will continue to coordinate their respective submission and review processes for veterinary drug applications to enable simultaneous product reviews. Further work in this area will also explore the expansion of Simultaneous Review to generic animal drug applications.|
The United States International Trade Administration website includes the 2019-20 RCC Work Plans.
Stakeholders participated in the joint 2018 Canada-US RCC Stakeholder Event in Washington DC. Their contributions helped to inform the 2019-20 RCC Work Plans.
The 2016-17 RCC Work Plans will be updated and reported on as information becomes available.
Previous RCC Work Plans:
Global discussions on international regulatory cooperation
Canada aims to advance regulatory cooperation globally by participating in fora such as the Asia-Pacific Economic Cooperation, the Organisation for Economic Cooperation and Development and the World Trade Organisation.
Report a problem or mistake on this page
- Date modified: